Pasithea Therapeutics Corp. (KTTAW) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $55.16M | +696.8% |
| 2024 | $6.92M | -57.6% |
| 2023 | $16.33M | -50.6% |
| 2022 | $33.09M | -37.5% |
| 2021 | $52.97M | +21638.8% |
| 2020 | $243.7K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $55.16M | +696.8% |
| 2024 | $6.92M | -57.6% |
| 2023 | $16.33M | -50.6% |
| 2022 | $33.09M | -37.5% |
| 2021 | $52.97M | +21638.8% |
| 2020 | $243.7K | — |